Jeff Garwood - Apr 7, 2022 Form 4 Insider Report for Medicine Man Technologies, Inc. (SHWZ)

Role: Director
Signature: /s/ Daniel R. Pabon as Attorney-in-Fact for Jeffrey R. Garwood
Stock symbol: SHWZ
Transactions as of: Apr 7, 2022
Transactions value $: $30,746
Form type: 4
Date filed: 4/11/2022, 05:17 PM
Previous filing: Apr 8, 2022
Next filing: Apr 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SHWZ	Common Stock	Purchase	$3.06K	+1.5K	+1.33%	$2.04	114K	Apr 7, 2022	Direct	F1
transaction	SHWZ	Common Stock	Purchase	$27.7K	+13.5K	+11.82%	$2.05	128K	Apr 8, 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $2.025 to $2.045 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $2.045 to $2.19 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $2.025 to $2.045 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $2.045 to $2.19 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.